The Indian Council for Medical Research (ICMR) said on Wednesday that the indiscriminate use of convalescent plasma therapy (CPT) against coronavirus disease (Covid-19) was not advisable, even as the number of infections across the country exceeded the 8.9 million mark. The main medical body carried out a phase II multicenter …
Read More »Explained: The Plasma Therapy Debate
Written by Anuradha Mascarenhas | Pune | Updated: October 27, 2020 9:22:04 am A 28-year-old man donates his blood plasma for Covid-19 treatment at the Delhi Plasma Bank at the Institute of Liver and Biliary Sciences. (Express photo: Tashi Tobgyal) Recently published findings on convalescent plasma therapy in Covid-19 patients …
Read More »Government Considers Excluding Plasma Therapy From National COVID-19 Guidelines
A study has shown that plasma therapy has not been effective in reducing the death rate in COVID-19 patients. The Union Ministry of Health stated Tuesday that it is considering excluding convalescent plasma therapy from its guidelines on COVID-19 treatment after its study found the procedure has not been effective …
Read More »India to rule out convalescent plasma therapy from Covid-19 treatment guidelines
In a development with huge ramifications regarding the treatment protocol for coronavirus infection, India has decided to remove convalescent plasma as an investigational therapy from its treatment protocol guidelines. The director general of the Indian Council of Medical Research (ICMR), Professor Balram Bhargava, said on Tuesday that “discussions are ongoing …
Read More »Antibodies Fade Rapidly in Recovery for COVID-19 Patients, Study Finds
Understanding how antibody levels change over time is critical not only to optimize the use of convalescent plasma but also to understand the efficacy of the vaccine. Antibody levels in the blood of COVID-19 patients drop rapidly during the weeks after their bodies have cleared the new coronavirus and symptoms …
Read More »Deputy CM Manish Sisodia from Delhi, suffering from Covid-19 and Dengue, administered plasma therapy
File photo of Deputy CM Manish Sisodia of Delhi. Sisodia had tested positive for COVID-19 on September 14 and was in home isolation. He was admitted to LNJP Hospital on Wednesday for treatment and tested positive for dengue a day later. News18.com Last update: September 25, 2020 11:32 PM IST …
Read More »Plasma Therapy Does Not Reduce Risk of Death From COVID-19, Says Top Medical Body ICMR Study
A trial was carried out in 464 moderately ill patients by the higher medical body. (Figurative) New Delhi: The Medical Research Council of India, in a study, said that plasma therapy for COVID-19 does not reduce the risk of death or slow the progression of the disease from a mild …
Read More »Plasma therapy cannot reduce COVID death rate or further disease progression: new study
New Delhi: The use of convalescent plasma therapy in coronavirus-infected patients does not help reduce mortality or progression to severe COVID-19, a multi-center study funded by the Indian Council of Medical Research (ICMR) has found. Also Read – IPL 2020: Chennai Super Kings Pacer Deepak Chahar Tests Negative for COVID-19, …
Read More »Coronavirus LIVE Updates: AstraZeneca Suspends Vaccine Trial; The vaccine will be implemented for all Brazilians in January 2021, says the Minister of Health
Meanwhile, a multi-center study funded by the Indian Council for Medical Research (ICMR) has found that the use of convalescent plasma therapy in coronavirus-infected patients does not help reduce mortality or progression to severe Covid-19. The ‘open parallel arm phase II multicenter randomized controlled trial’ (PLACID trial) was conducted in …
Read More »Coronavirus LIVE Updates: AstraZeneca Suspends Vaccine Trial Due to ‘Unexplained’ Illness in Volunteer; Plasma therapy not beneficial in reducing mortality, study says
Meanwhile, a multi-center study funded by the Indian Council for Medical Research (ICMR) has found that the use of convalescent plasma therapy in coronavirus-infected patients does not help reduce mortality or progression to severe Covid-19. The ‘open parallel arm phase II multicenter randomized controlled trial’ (PLACID trial) was conducted in …
Read More »